From: A reproducible brain tumour model established from human glioblastoma biopsies
Case | Diagnosis | Gender | Age | Culture time, days | Tumour take, % | Survival, mean days ± SEM | Passage, yes/no |
---|---|---|---|---|---|---|---|
1 | GBM | f | 46 | 4 | 6/6 (100) | 104.5 ± 1.4 | yes |
2 | GBM | m | 70 | 15 | 12/13 (92) | 117.5 ± 8.6 | yes |
3 | GBM | m | 31 | 19 | 4/5 (80) | 169.5 ± 22.1 | no |
4 | GBM | f | 31 | 4 | 7/7 (100) | 97 ± 1.7 | yes |
5 | GBM | m | 70 | 23 | 8/8 (100) | 119.5 ± 3.5 | yes |
6 | GBM | m | 45 | 24 | 2/10 (20) | 93.5 ± 10.6 | no |
7 | GBM | m | 47 | 3 | 7/7 (100) | 126.5 ± 2.9 | yes |
8 | GBM | m | 47 | 3 | 12/14 (86) | 137.5 ± 5 | no |
9 | GBM | m | 62 | 6 | 3/5 (60) | 252 ± 1.6 | no |
10 | GBM | m | 60 | 3 | 6/6 (100) | 83 ± 6.6 | no |
11 | GBM | m | 38 | 7 | 3/3 (100) | 94.5 ± 7.7 | no |
12 | GBM | m | 64 | 4 | 6/6 (100) | 58.5 ± 4.3 | yes |
13 | G-A | m | 49 | 9 | 0/4 (0) | -- | no |
14 | GBM | f | 81 | 4 | 7/8 (88) | 168.5 ± 14.1 | yes |
15 | GBM | f | 64 | 10 | 8/8 (100) | 125.5 ± 14 | yes |
16 | GBM | f | 46 | 17 | 8/10 (80) | 83 ± 2.4 | no |
17 | F-A | f | 38 | 56 | 0/6 (0) | -- | no |
18 | GBM | m | 64 | 26 | 6/7 (86) | 134.5 ± 23.3 | yes |
19 | G-A | m | 34 | 54 | 5/6 (83) | 326.5 ± 20 | no |
20 | GBM | m | 69 | 17 | 5/6 (83) | 81.5 ± 3.4 | yes |
21 | OA III | f | 32 | 7 | 0/10 (0) | -- | no |
22 | GBM | m | 61 | 21 | 0/2 (0) | -- | no |
23 | GBM | f | 23 | 67 | 6/7 (86) | 139 ± 8.6 | no |
24 | GBM | m | 60 | 28 | 6/8 (75) | 126.5 ± 19 | no |
25 | GBM | f | 73 | 25 | 2/4 (50) | 118.0 ± 40 | no |
26 | GBM | f | 66 | 8 | 5/8 (63) | 111 ± 21 | yes |
27 | GBM | m | 56 | 35 | 2/4 (50) | 68.5 ± 2.1 | no |
28 | GBM | m | 55 | 7 | 3/5 (60) | 92 ± 12.9 | no |
29 | GBM | f | 74 | 8 | 3/4 (75) | 102 ± 6 | no |